SET and leukemia: Based on this and the fundamental role played by PP2A-modulated kinases on the survival and resistance of KMT2A-R-leukemic cells [17, 19, 30], we herein investigated the role of the PP2A endogenous inhibitor SET in KMT2A-R leukemia.